{"id":"https://openalex.org/W2590000359","doi":"https://doi.org/10.1182/blood.v126.23.2474.2474","title":"RAR-Alpha Targeting Compounds Overcome Bone Marrow (BM) Stromal Protection of AML By CYP26","display_name":"RAR-Alpha Targeting Compounds Overcome Bone Marrow (BM) Stromal Protection of AML By CYP26","publication_year":2015,"publication_date":"2015-12-03","ids":{"openalex":"https://openalex.org/W2590000359","doi":"https://doi.org/10.1182/blood.v126.23.2474.2474","mag":"2590000359"},"language":"en","primary_location":{"id":"doi:10.1182/blood.v126.23.2474.2474","doi":"https://doi.org/10.1182/blood.v126.23.2474.2474","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v126.23.2474.2474","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5051026089","display_name":"Kelly J. Norsworthy","orcid":"https://orcid.org/0000-0002-8462-9994","observed_orcids":["https://orcid.org/0000-0002-8462-9994"]},"institutions":[{"id":"https://openalex.org/I145311948","display_name":"Johns Hopkins University","ror":"https://ror.org/00za53h95","country_code":"US","type":"education","lineage":["https://openalex.org/I145311948"]},{"id":"https://openalex.org/I4210164401","display_name":"Sidney Kimmel Comprehensive Cancer Center","ror":"https://ror.org/05m5b8x20","country_code":"US","type":"facility","lineage":["https://openalex.org/I2799853436","https://openalex.org/I4210164401"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kelly J Norsworthy","raw_affiliation_strings":["Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD","institution_ids":["https://openalex.org/I145311948","https://openalex.org/I4210164401"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067960397","display_name":"Daniela Hernandez","orcid":"https://orcid.org/0000-0001-5960-160X","observed_orcids":["https://orcid.org/0000-0001-5960-160X"]},"institutions":[{"id":"https://openalex.org/I145311948","display_name":"Johns Hopkins University","ror":"https://ror.org/00za53h95","country_code":"US","type":"education","lineage":["https://openalex.org/I145311948"]},{"id":"https://openalex.org/I4210164401","display_name":"Sidney Kimmel Comprehensive Cancer Center","ror":"https://ror.org/05m5b8x20","country_code":"US","type":"facility","lineage":["https://openalex.org/I2799853436","https://openalex.org/I4210164401"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Daniela Hernandez","raw_affiliation_strings":["Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD","institution_ids":["https://openalex.org/I145311948","https://openalex.org/I4210164401"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051010633","display_name":"Meng Su","orcid":"https://orcid.org/0000-0002-6105-3320","observed_orcids":["https://orcid.org/0000-0002-6105-3320"]},"institutions":[{"id":"https://openalex.org/I145311948","display_name":"Johns Hopkins University","ror":"https://ror.org/00za53h95","country_code":"US","type":"education","lineage":["https://openalex.org/I145311948"]},{"id":"https://openalex.org/I4210164401","display_name":"Sidney Kimmel Comprehensive Cancer Center","ror":"https://ror.org/05m5b8x20","country_code":"US","type":"facility","lineage":["https://openalex.org/I2799853436","https://openalex.org/I4210164401"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Meng Su","raw_affiliation_strings":["Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD","institution_ids":["https://openalex.org/I145311948","https://openalex.org/I4210164401"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001506926","display_name":"Megan E McCray","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I145311948","display_name":"Johns Hopkins University","ror":"https://ror.org/00za53h95","country_code":"US","type":"education","lineage":["https://openalex.org/I145311948"]},{"id":"https://openalex.org/I4210164401","display_name":"Sidney Kimmel Comprehensive Cancer Center","ror":"https://ror.org/05m5b8x20","country_code":"US","type":"facility","lineage":["https://openalex.org/I2799853436","https://openalex.org/I4210164401"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Megan E McCray","raw_affiliation_strings":["Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD","institution_ids":["https://openalex.org/I145311948","https://openalex.org/I4210164401"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054059858","display_name":"Christopher Esteb","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I145311948","display_name":"Johns Hopkins University","ror":"https://ror.org/00za53h95","country_code":"US","type":"education","lineage":["https://openalex.org/I145311948"]},{"id":"https://openalex.org/I4210164401","display_name":"Sidney Kimmel Comprehensive Cancer Center","ror":"https://ror.org/05m5b8x20","country_code":"US","type":"facility","lineage":["https://openalex.org/I2799853436","https://openalex.org/I4210164401"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Christopher A Esteb","raw_affiliation_strings":["Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD","institution_ids":["https://openalex.org/I145311948","https://openalex.org/I4210164401"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111860565","display_name":"Roshantha A.S. Chandraratna","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210151849","display_name":"Io Therapeutics (United States)","ror":"https://ror.org/05hy8nr95","country_code":"US","type":"company","lineage":["https://openalex.org/I4210151849"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Roshantha A Chandraratna","raw_affiliation_strings":["Io Therapeutics, Inc., Santa Ana, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Io Therapeutics, Inc., Santa Ana, CA","institution_ids":["https://openalex.org/I4210151849"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012395020","display_name":"Bruce Douglas Smith","orcid":"https://orcid.org/0000-0002-0903-7390","observed_orcids":["https://orcid.org/0000-0002-0903-7390"]},"institutions":[{"id":"https://openalex.org/I145311948","display_name":"Johns Hopkins University","ror":"https://ror.org/00za53h95","country_code":"US","type":"education","lineage":["https://openalex.org/I145311948"]},{"id":"https://openalex.org/I4210164401","display_name":"Sidney Kimmel Comprehensive Cancer Center","ror":"https://ror.org/05m5b8x20","country_code":"US","type":"facility","lineage":["https://openalex.org/I2799853436","https://openalex.org/I4210164401"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"B. Douglas Smith","raw_affiliation_strings":["Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD","institution_ids":["https://openalex.org/I145311948","https://openalex.org/I4210164401"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036664711","display_name":"Richard John Jones","orcid":"https://orcid.org/0000-0002-2946-1164","observed_orcids":["https://orcid.org/0000-0002-2946-1164"]},"institutions":[{"id":"https://openalex.org/I145311948","display_name":"Johns Hopkins University","ror":"https://ror.org/00za53h95","country_code":"US","type":"education","lineage":["https://openalex.org/I145311948"]},{"id":"https://openalex.org/I4210164401","display_name":"Sidney Kimmel Comprehensive Cancer Center","ror":"https://ror.org/05m5b8x20","country_code":"US","type":"facility","lineage":["https://openalex.org/I2799853436","https://openalex.org/I4210164401"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Richard J Jones","raw_affiliation_strings":["Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD","institution_ids":["https://openalex.org/I145311948","https://openalex.org/I4210164401"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5069374229","display_name":"Gabriel Ghiaur","orcid":"https://orcid.org/0000-0002-3955-7944","observed_orcids":["https://orcid.org/0000-0002-3955-7944"]},"institutions":[{"id":"https://openalex.org/I145311948","display_name":"Johns Hopkins University","ror":"https://ror.org/00za53h95","country_code":"US","type":"education","lineage":["https://openalex.org/I145311948"]},{"id":"https://openalex.org/I4210164401","display_name":"Sidney Kimmel Comprehensive Cancer Center","ror":"https://ror.org/05m5b8x20","country_code":"US","type":"facility","lineage":["https://openalex.org/I2799853436","https://openalex.org/I4210164401"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Gabriel Ghiaur","raw_affiliation_strings":["Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD","institution_ids":["https://openalex.org/I145311948","https://openalex.org/I4210164401"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5001506926","https://openalex.org/A5067960397","https://openalex.org/A5111860565"],"corresponding_institution_ids":["https://openalex.org/I145311948","https://openalex.org/I4210151849","https://openalex.org/I4210164401"],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":0.1446,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":{"value":0.55536971,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":94},"biblio":{"volume":"126","issue":"23","first_page":"2474","last_page":"2474"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11559","display_name":"Retinoids in leukemia and cellular processes","score":0.9961000084877014,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11559","display_name":"Retinoids in leukemia and cellular processes","score":0.9961000084877014,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.003599999938160181,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11072","display_name":"Peroxisome Proliferator-Activated Receptors","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/acute-myeloid-leukemia","display_name":"acute myeloid leukemia","score":0.9810000061988831},{"id":"https://openalex.org/keywords/retinoic-acid-receptor-alpha","display_name":"retinoic acid receptor alpha","score":0.781000018119812},{"id":"https://openalex.org/keywords/retinoic-acid-receptor-gamma","display_name":"retinoic acid receptor gamma","score":0.9860000014305115},{"id":"https://openalex.org/keywords/cyp26b1","display_name":"CYP26B1","score":0.9850000143051147},{"id":"https://openalex.org/keywords/bone-marrow-stroma","display_name":"bone marrow stroma","score":0.8240000009536743},{"id":"https://openalex.org/keywords/leukemia-microenvironment","display_name":"leukemia microenvironment","score":0.6359999775886536},{"id":"https://openalex.org/keywords/all-trans-retinoic-acid","display_name":"all-trans retinoic acid","score":0.8169999718666077},{"id":"https://openalex.org/keywords/am80","display_name":"Am80","score":0.9110000133514404},{"id":"https://openalex.org/keywords/cd437","display_name":"CD437","score":0.9779999852180481},{"id":"https://openalex.org/keywords/myeloid-differentiation","display_name":"myeloid differentiation","score":0.7919999957084656},{"id":"https://openalex.org/keywords/differentiation-therapy","display_name":"differentiation therapy","score":0.5109999775886536}],"concepts":[{"id":"https://openalex.org/C127561419","wikidata":"https://www.wikidata.org/wiki/Q224527","display_name":"Downregulation and upregulation","level":3,"score":0.8330219984054565},{"id":"https://openalex.org/C2781121885","wikidata":"https://www.wikidata.org/wiki/Q425517","display_name":"Retinoic acid","level":3,"score":0.7075813412666321},{"id":"https://openalex.org/C16930146","wikidata":"https://www.wikidata.org/wiki/Q4381253","display_name":"Stromal cell","level":2,"score":0.6137062311172485},{"id":"https://openalex.org/C117262875","wikidata":"https://www.wikidata.org/wiki/Q5135057","display_name":"Clonogenic assay","level":3,"score":0.5762732625007629},{"id":"https://openalex.org/C148738053","wikidata":"https://www.wikidata.org/wiki/Q210861","display_name":"Cellular differentiation","level":3,"score":0.555541455745697},{"id":"https://openalex.org/C120197328","wikidata":"https://www.wikidata.org/wiki/Q2838685","display_name":"Retinoic acid receptor","level":4,"score":0.5152400135993958},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5005440711975098},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.46958842873573303},{"id":"https://openalex.org/C2780007613","wikidata":"https://www.wikidata.org/wiki/Q546523","display_name":"Bone marrow","level":2,"score":0.4664420783519745},{"id":"https://openalex.org/C2778938600","wikidata":"https://www.wikidata.org/wiki/Q389934","display_name":"Agonist","level":3,"score":0.43568649888038635},{"id":"https://openalex.org/C2778729363","wikidata":"https://www.wikidata.org/wiki/Q11688946","display_name":"Myeloid leukemia","level":2,"score":0.4278068542480469},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.42430204153060913},{"id":"https://openalex.org/C2779963572","wikidata":"https://www.wikidata.org/wiki/Q29417","display_name":"Tretinoin","level":4,"score":0.41116076707839966},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.404737651348114},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.3921681344509125},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.36305344104766846},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.329722136259079},{"id":"https://openalex.org/C81885089","wikidata":"https://www.wikidata.org/wiki/Q189082","display_name":"Cell culture","level":2,"score":0.21454626321792603},{"id":"https://openalex.org/C190283241","wikidata":"https://www.wikidata.org/wiki/Q14599311","display_name":"Apoptosis","level":2,"score":0.21023961901664734},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.14821571111679077},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/blood.v126.23.2474.2474","doi":"https://doi.org/10.1182/blood.v126.23.2474.2474","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v126.23.2474.2474","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9763000011444092}],"sustainable_development_goals_aurora":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.5600000023841858}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2213325450","https://openalex.org/W1602220148","https://openalex.org/W7099809836","https://openalex.org/W1998528257","https://openalex.org/W1817065479","https://openalex.org/W2555682000","https://openalex.org/W2132791225","https://openalex.org/W1997473510","https://openalex.org/W2562275208","https://openalex.org/W2010083101"],"abstract_inverted_index":{"Abstract":[0],"All-trans":[1],"retinoic":[2,47],"acid":[3,48],"(ATRA)":[4],"causes":[5],"terminal":[6,59],"differentiation":[7,38,60,88,102,130,139,355,519],"and":[8,33,53,55,86,99,103,115,142,168,204,222,246,265,270,293,333,396,407,459,467,503,531,546,552],"apoptosis":[9],"of":[10,61,66,97,131,137,160,166,196,216,259,267,304,329,342,356,371,382,394,398,400,417,429,469,479,514,520,528,560,564,566,595],"non-APL":[11,581],"AML":[12,319,358,495,511,521,554],"cells":[13,36,134,181,402,446,555],"in":[14,182,324,361,368,412,422,464,474,557,580],"vitro,":[15],"but":[16,63,364,457,523],"has":[17],"not":[18,57,517],"proven":[19],"clinically":[20],"effective.":[21],"We":[22,347,569],"have":[23,307,348,505],"recently":[24],"shown":[25,350],"that":[26,351,501],"BM":[27,179,331,372,561],"stroma":[28,180,332,391,418,432,470,562],"expressing":[29],"CYP26":[30,104,315,384,539,567],"inactivates":[31],"ATRA":[32,44,106,190,352],"protects":[34],"leukemia":[35],"from":[37,427,449,477],"(Su":[39,385],"M":[40,386],"et":[41,387],"al":[42],"2015).":[43,389],"signals":[45],"through":[46],"receptors":[49],"(RARs)":[50],"\u03b1,":[51],"\u03b2":[52],"\u03b3":[54,504],"induces":[56],"only":[58,236],"AML,":[62,91],"also":[64,308,439],"upregulation":[65,136,195,207,215,393,527],"CYP26,":[67],"potentially":[68],"forming":[69],"an":[70,78,592],"even":[71,556],"more":[72],"protective":[73],"niche":[74,509],"for":[75,90,228,252,273,282],"leukemia.":[76],"In":[77,149,230,497,537],"effort":[79],"to":[80,101,202,279,311,314,344,525,535,550],"decouple":[81],"these":[82,305],"two":[83,288],"biological":[84],"effects":[85,238,487,507],"improve":[87],"therapy":[89],"we":[92,175,284,499],"investigated":[93],"the":[94,151,164,187,232,256,287,325,369,413,465,526,558],"relative":[95],"contribution":[96],"RAR\u03b1":[98,111,167,289,502,541],"RAR\u03b3":[100,169,276,515],"upregulation.":[105],"(pan-RAR":[107],"agonist),":[108],"AM80":[109,254,292,337,406,420,458,545],"(strong":[110],"agonist,":[112],"weak":[113],"RAR\u03b3),":[114],"IRX5183":[116,234,339,408,460,472,547,579],"(RAR\u03b1-specific":[117],"agonist;":[118],"previously":[119,349],"known":[120],"as":[121,302],"NRX":[122],"195183,":[123],"Io":[124,585],"Therapeutics,":[125,586],"Inc.)":[126],"all":[127],"induced":[128,191],"significant":[129],"NB4":[132,401],"APL":[133],"(i.e.,":[135],"myeloid":[138],"antigen":[140],"CD11b":[141,395,426],"decreased":[143],"clonogenic":[144,475],"activity)":[145],"at":[146,198,208,220,225,244,249,263,340],"0.1":[147,345],"\u03bcM.":[148,346],"contrast,":[150,231,538],"RAR\u03b3-specific":[152],"agonist":[153],"CD437":[154,212],"(0.1":[155],"\u03bcM)":[156],"produced":[157],"no":[158],"evidence":[159],"differentiation.":[161],"To":[162],"determine":[163],"impact":[165],"signaling":[170],"on":[171,239,435,454,483,508,591],"stromal":[172,383,529],"CYP26B1":[173,197,217,240,260],"levels,":[174],"treated":[176,334],"murine":[177],"OP9":[178,330],"low":[183],"serum":[184],"conditions":[185],"with":[186,335],"aforementioned":[188],"agents.":[189],"a":[192,423,573],"40.5\u00b130.1":[193],"fold":[194,206,219,224,243,248,424],"24h":[199,221,245,264],"(p=0.02":[200],"compared":[201],"control)":[203],"24.7\u00b120.4":[205],"48":[209],"hours":[210],"(p=0.03).":[211],"showed":[213,255,409],"progressive":[214],"(14.4\u00b15.2":[218],"27.7\u00b18.8":[223],"48h,":[226,250],"p<0.01":[227,251,272],"both).":[229,253,274],"RAR\u03b1-specific":[233],"had":[235],"modest":[237],"levels":[241,261],"(2.9\u00b10.9":[242],"2.7\u00b10.2":[247],"highest":[257],"up-regulation":[258],"both":[262,303,405,463],"48h":[266],"treatment":[268],"(29.1\u00b17.9":[269],"77\u00b124.4,":[271],"Since":[275],"activation":[277],"appeared":[278],"be":[280,312,378],"dispensable":[281],"differentiation,":[283,301],"tested":[285],"if":[286],"active":[290,462,542],"agents,":[291],"IRX5183,":[294],"could":[295],"bypass":[296],"stromal-mediated":[297],"protection":[298],"against":[299,443],"ATRA-induced":[300],"compounds":[306],"been":[309],"reported":[310],"resistant":[313],"mediated":[316],"degradation.":[317],"Several":[318],"cell":[320,359],"lines":[321,360],"were":[322,461,488],"cultured":[323],"presence":[326,370,414,466,559],"or":[327,338,415,597],"absence":[328,416,468],"ATRA,":[336,404],"concentrations":[341],"0.01":[343],"can":[353,377],"induce":[354,518],"most":[357],"stroma-free":[362],"conditions,":[363],"it":[365],"is":[366],"inactive":[367],"stroma;":[373],"further,":[374],"its":[375],"effect":[376],"restored":[379],"by":[380,403],"inhibition":[381,397],"al.":[388],"Whereas":[390],"blocked":[392,440],"clonogenicity":[399],"similar":[410],"activity":[411,442],"(e.g.":[419,471],"resulted":[421,473],"change":[425],"control":[428,450,478],"9.8\u00b15.3":[430],"off":[431],"vs":[433,452,481,510],"11.8\u00b18.4":[434],"stroma,":[436,455,484],"p=NS).":[437,485],"Stroma":[438],"ATRA's":[441],"NPM1-mutated":[444],"OCI-AML3":[445],"(clonogenic":[447],"recovery":[448,476],"6.4\u00b13.3%":[451],"61.4\u00b112.2%":[453],"p=0.002),":[456],"7.3\u00b12.5%":[480],"11.2\u00b12.8%":[482],"Similar":[486],"observed":[489],"using":[490,578],"Kasumi-1":[491],"core":[492],"binding":[493],"factor":[494],"cells.":[496,512],"conclusion,":[498],"found":[500],"distinct":[506],"Stimulation":[513],"does":[516],"cells,":[522],"leads":[524],"CYP26B1,":[530],"thus":[532],"enhanced":[533],"resistance":[534],"ATRA.":[536],"resistant,":[540],"synthetic":[543],"retinoids":[544],"are":[548,570],"able":[549],"differentiate":[551],"eliminate":[553],"regardless":[563],"induction":[565],"expression.":[568],"currently":[571],"exploring":[572],"phase":[574],"I/II":[575],"clinical":[576],"trial":[577],"AML.":[582],"Disclosures":[583],"Chandraratna:":[584],"Inc.:":[587],"Equity":[588],"Ownership,":[589],"Membership":[590],"entity's":[593],"Board":[594],"Directors":[596],"advisory":[598],"committees,":[599],"Other:":[600],"President.":[601]},"counts_by_year":[{"year":2017,"cited_by_count":1}],"updated_date":"2026-09-22T06:50:58.402377","created_date":"2017-03-03T00:00:00"}